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Abstract
Background: Mesenchymal stromal cells (MSCs) are widely used in clinical trials for bone repair and regeneration.
Despite previous evidence showing a prominent osteogenic potential of 2D cultured CD271 enriched MSCs, the
osteogenic potential of CD271 enriched cells cultured on 3D scaffold is unknown. Apatite-wollastonite glass ceramic
(A-W) is an osteoconductive biomaterial shown to be compatible with MSCs. This is the first study comparing the
attachment, growth kinetics, and osteogenic potential of two MSC populations, namely heterogeneous plastic
adherence MSCs (PA-MSCs) and CD271-enriched MSCs (CD271-MSCs), when cultured on A-W 3D scaffold.
Results: The paired MSC populations were assessed for their attachment, growth kinetics and ALP activity using
confocal and scanning electron microscopy and the quantifications of DNA contents and p-nitrophenyl (pNP)
production respectively. While the PA-MSCs and CD271-MSCs had similar expansion and tri-lineage differentiation
capacity during standard 2D culture, they showed different proliferation kinetics when seeded on the A-W
scaffolds. PA-MSCs displayed a well-spread attachment with more elongated morphology compared to CD271-
MSCs, signifying a different level of interaction between the cell populations and the scaffold surface. Following
scaffold seeding PA-MSCs fully integrated into the scaffold surface and showed a stronger propensity for
osteogenic differentiation as indicated by higher ALP activity than CD271-MSCs. Furthermore, A-W scaffold
seeded uncultured non-enriched bone marrow mononuclear cells also demonstrated a higher proliferation rate
and greater ALP activity compared to their CD271-enriched counterpart.
Conclusions: Our findings suggest that CD271-positive enrichment of a population is not beneficial for
osteogenesis when the cells are seeded on A-W scaffold. Furthermore, unselected heterogeneous MSCs or BM-
MNCs are more promising for A-W scaffold based bone regeneration. This leads to a conclusion of broader
clinical relevance for tissue engineering: on the basis of our observations here the osteogenic potential observed
in 2D cell culture should not be considered indicative of likely performance in a 3D scaffold based system, even
when one of the cell populations is effectively a subset of the other.
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Background
Bone tissue regeneration is a complex process contribut-
ing to biological repair of bone defects which can de-
velop in patients with a variety of complications.
Mesenchymal stromal cells (MSCs) and bioactive scaf-
folds are increasingly used in translational research and
clinical applications to enhance bone repair/regeneration
[1, 2]. MSCs are multipotent progenitor cells with prom-
ising therapeutic potential for bone repair/regeneration,
owing to their intrinsic ability to differentiate into osteo-
blasts and secrete paracrine factors that can enhance
bone regeneration [3, 4]. According to the minimal
criteria to define human MSCs proposed by the Inter-
national Society for Cellular Therapy (ISCT), among
other features, MSCs should express surface markers
CD73, CD90 and CD105 and lack of expression of
haematopoietic markers CD45, CD34, CD19 and CD14
[5]. These minimal criteria were updated specifically for
adipose tissue derived MSCs as they express CD34 [6].
Additional surface markers such as CD29, CD44 were
also used to aid characterisation of MSCs from different
tissues [7]. Over the past decade extensive research has
endeavored to improve the therapeutic potency of MSCs
through using phenotypically and functionally selected
MSC sub-populations, with CD271 being a widely used
marker for selecting functional MSC sub-populations [8].
Cell surface protein CD271 is recognized as a marker for
MSC precursors in bone marrow and CD271-enriched
bone marrow mononuclear cells (BM-MNCs) have been
shown to yield more homogeneous MSC population with
more potent tissue repair functions [9–12]. In standard
2D culture MSCs derived from CD271-enriched BM-
MNCs have been shown to have higher proliferation rates
and greater osteogenic differentiation potential compared
to those from non-enriched counterparts [13]. Further
study using 2D culture conditions evidenced a higher
expression of osteoblast marker gene (OPN) in CD271-
enriched BM-MSCs in comparison to non-enriched MSCs
[14]. So far no study has been reported comparing hetero-
geneous and CD271-enriched MSC populations when
cultured on 3D scaffold.
The implantation of a 3D scaffold into a bone defect is
a promising tissue engineering approach to enhance
osteogenic repair and regeneration by providing an opti-
mal environment for cell attachment, proliferation and
differentiation [15, 16]. A range of biomaterials has been
used in combination with heterogeneous MSCs for bone
engineering [17–20]. Apatite wollastonite glass ceramic
(A-W) is an osteoconductive material which has been
previously used clinically for load-bearing musculoskel-
etal repair [21]. It has the ability to bond to bone and to
stimulate osteogenic differentiation in the surrounding
cells [22]. Our previous work has led to the development
of custom-built bone scaffold using heterogeneous
MSCs and A-W glass-ceramics [23]. The biocompatibil-
ity of A-W scaffold and heterogeneous MSCs has been
demonstrated through both in vitro dynamic culture and
in vivo implantation in nude mice [24]. A-W is an
attractive material for bone tissue engineering applica-
tions as it combines osteoconductivity with excellent
mechanical properties: even when porous the mechan-
ical properties can approach those of cortical bone [25].
This present study aimed to evaluate the attachment,
proliferation and osteogenic potential of paired hetero-
geneous and CD271-enriched MSC populations when
cultured on A-W 3D scaffolds.
Results
The frequency of CD271highCD45- cells before and after
CD271 enrichment
Prior to CD271 enrichment the average frequency of
CD271highCD45- cells in the initial BM-MNCs was as low
as 0.028% (±0.009). After CD271-enrichment the fre-
quency of CD271highCD45- cells was elevated to 12.7% (±
2.0). The enrichment resulted in an average of 1338-fold
(±468) increase in the CD271highCD45- cells (Fig. 1a, b).
PA-MSC and CD271-MSC show similar characteristics in
2D culture
Paired MSCs were expanded in 2D culture up to 6
passages. The rate of proliferation was recorded during
expansion. No difference was observed in the number of
cumulative population doublings of PA-MSCs and
CD271-MSCs (Fig. 2a). At passage 3 MSC populations
were characterised using the standard criteria set by
ISCT [5]. The results demonstrated that both PA-MSCs
and CD271-MSCs displayed the standard MSC character-
istics including plastic adherent, fibroblast-like morph-
ology (Fig. 2b, c), ability to differentiate into osteogenic,
chondrogenic and adipogenic lineages (Fig. 2d, e), positive
Fig. 1 Frequency of CD271highCD45- cells before and after
enrichment. The percentage (a) and representative flow cytometry
dot plots (b) of CD271highCD45- cells in BM-MNCs before and after
CD271-enrichment. Prior to the flow dot plot shown a live cell gate
was applied. ***p < 0.0001 (paired t-test), Data shown are from 14
independent experiments
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expression of cell surface markers CD73, CD90, and
CD105 and lack of expression of the hematopoietic
lineage markers CD14, CD19, CD34, CD45 and HLA-DR
(Fig. 2f,g). The characteristics expressed by CD271-MSCs
were indistinguishable from those displayed by PA-MSCs.
A-W scaffold seeded PA-MSC and CD271-MSC display
different morphology
ImageJ analysis of Phalloidin and DAPI stained scaffolds
(Fig. 3a, b) allowed for the quantification of cell size and
shape. A-W scaffold seeded PA-MSCs were significantly
larger and more elongated in shape compared to the
CD271-MSCs 24 h after seeding (Fig. 3c) (p = 0.0055).
Circularity, a measurement between 0 and 1, indicates
how round a shape is, with 0 representing a straight line
and 1 representing a perfect circle. PA-MSCs showed
circularity values predominately at the linear end of the
scale with 80% of PA-MSCs exhibiting a circularity range
between 0.1 and 0.3 while over 70% of CD271-MSCs
displayed middle range of circularity values between 0.3
and 0.6. (Fig. 3d), signifying a different level of attach-
ment and interaction with the scaffold surface between
PA-MSCs and CD271-MSCs.
A-W scaffold seeded PA-MSC and CD271-MSC show
different growth kinetic and varied scaffold integration
The proliferation of A-W scaffold seeded MSCs was
analysed using DNA content as a quantitative readout
(Fig. 4a). Prior to being seeded on the scaffold (day 0)
Both MSC populations showed similar base levels of
DNA (76.7 ± 12.3 ng/ml and 75.9 ± 8.5 ng/ml respect-
ively). At day 1, day 3 and day 7, there was a significant
difference between the DNA content from scaffold
seeded PA-MSCs and CD271-MSCs (p ≤ 0.001). At day
1 and 3, this difference signified a larger PA-MSC popu-
lation, but by day 7 this was reversed. Interestingly,
between day 1 and day 3 both PA-MSCs and CD271-
MSCs lost a similar amount of DNA (100–120 ng/ml).
For the CD271-MSCs this represented a loss of 62% (±
2%) of the population, while for the PA-MSCs this was
only a loss of 37% (±2%). At day 7 the CD271-MSC
population had increased, while the PA-MSC population
had dropped further. Despite these differences, at day 14
the DNA concentration from the PA-MSC and CD271-
MSC seeded scaffolds was almost identical, with 260.45
ng/ml (±7.5) and 263.2 ng/ml (±4.4) for PA-MSC and
CD271-MSC respectively. Scanning electron microscopy
images taken at day 14 showed that the scaffold seeded
PA-MSCs had largely integrated into the scaffold hence
less visible on the scaffold surface. On the contrary, the
CD271-MSCs were highly visible on the surface of the
scaffold (Fig. 4b-e), signifying poor integration into the
scaffold compared to the PA-MSC population.
A-W scaffold seeded PA-MSC and CD271-MSC show
different osteogenic potential
MSC seeded scaffolds were fixed after 14 days of
osteogenic induction and analysed using high resolution
scanning electron microscopy. Bone formation related
structures were observed on the surface of the scaffold,
such as fibrous ECM (web-like structure) and areas of
mineralisation nodules as illustrated in Fig. 5a-d. Both
structures were more prevalent on the PA-MSC seeded
scaffolds compared to the CD271-MSC seeded scaffolds,
Fig. 2 Characteristics of PA-MSC and CD271-MSC in 2D culture. Basic characteristics of paired PA-MSCs and CD271-MSCs were assessed during
2D in vitro expansion. a The cumulative population doublings of paired PA-MSC and CD271-MSC. b, c Representative phase contrast images
showing the fibroblast-like morphology of PA-MSC (top row) and CD271-MSC (bottom row) respectively. Scale bars indicate 200 μm. d, e
Representative images showing tri-lineage differentiation of PA-MSC and CD271-MSC respectively. From left to right: adipogenic differentiation
(oil-red-O staining lipid vacuoles), osteogenic differentiation (ALP stain in blue and mineralization in black), chondrogenic differentiation (alcian
blue staining glycosaminoglycans). Scale bars on all images indicate 200 μm. All images were taken on a NIKON spinning disk microscope. f, g
Graphs showing the representative histogram and the percentage of positive cells for the phenotypic markers of MSCs. Error bars represent the
SEM of 3 independent experiments
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indicative of a greater osteogenic potential of PA-MSCs
on A-W scaffolds. The osteogenic potential of A-W scaf-
fold seeded MSCs was also quantified using ALP activity
as a readout, normalised to DNA content, after culturing
the scaffolds in osteogenic media for 3, 7 and 14 days. A
continued increase in ALP activity was observed in PA-
MSCs across the 14 days of osteogenic induction (though
not statistically significant) while little increase was ob-
served in the ALP activity of CD271-MSCs (Fig. 5e).
To assess if the variation in osteogenic potential
between the two A-W scaffold seeded MSC populations
was due to culture expansion, freshly isolated uncultured
BM-MNCs, with or without CD271-enrichment, were
seeded onto A-W 3D scaffold and cultured in osteogenic
media. Following 21 days of osteogenic induction the cell
growth and osteogenic potential were analysed using
DNA content and ALP activity as a quantitative readout
respectively. The DNA content was significantly higher
Fig. 3 Morphology of A-W scaffold seeded PA-MSC and CD271-MSC. Representative images of scaffold seeded PA-MSC (a) and CD271-MSC (b) after
24 h culture in MSC expansion medium, in which the boxed areas were illustrated in higher magnification as (c) and (d) respectively. Phalloidin (red)
stains the F-actin cytoskeleton showing elongated cell morphology. DAPI (blue) stains the nucleus and white/grey shows the surface of the scaffold.
Images were taken with a Leica TCS SP2 UV AOBS MP scanning confocal microscope. Scale bars represent 150 μm (a) & (b) and 600 μm (c) & (d)
respectively. Images are representative of 3 independent experiments. Analysis of morphology is shown with cell area (e) and circularity (f). Circularity
is presented as frequency of occurrence in percentage. **p≤ 0.01 (paired t-test). Error bars represent the SEM of 4 independent experiments
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in non-enriched BM-MNCs compared to the CD271-
enriched (p = 0.026) (Fig. 5f ). Non-enriched BM-
MNCs also showed an over 5-fold higher ALP activity
(9621.8 μg/ml pNP/DNA μg/ml ± 5018.9) than that of
CD271-enriched BM-MNCs (1781.6 μg/ml pNP/DNA
μg/ml ± 601.8), although the statistical significance
was not reached (Fig. 5g).
Discussion
Our results indicate a higher osteogenic potential of A-W
scaffold seeded heterogeneous PA-MSC compared to
CD271-enriched MSC, despite previous evidence showing
that purified uncultured CD271 positive BM-MNCs or 2D
cultured CD271 enriched MSCs possess prominent osteo-
genic and Wnt signaling activity compared to their unse-
lected or uncultured counterparts [14, 26, 27]. However,
those results were generated from standard 2D plastic
adhering cultures and the method used for CD271 enrich-
ment in the reported study is different from the present
study. To date, only one other study has combined cul-
tured CD271-MSCs with a natural and synthetic polymer
scaffold for osteogenic regeneration [28] by seeding rabbit
culture expanded CD271-MSCs onto a 2D poly[ɛ-capro-
lactone]/thermoplastic zein-hydroxyapatite (PCL/TZ-HA)
disk. This study reported a stronger osteogenic potential
of CD271-MSCs than the PA-MSCs, but again was based
on a 2D study. It is well documented that MSCs grown on
2D or 3D structural compositions have widely different
properties [29–31], and here we demonstrate that, for our
scaffold and cell populations, the differences between 2D
and 3D culture can mean that results from 2D culture are
a poor predictor of performance on a 3D scaffold.
Fig. 4 Growth kinetics of A-W scaffold seeded PA-MSC and CD271-MSC. a Graph showing the concentration of DNA obtained from MSC seeded
scaffolds cultured in MSC expansion medium for 1, 3, 7 and 14 days. Day 0 value was obtained from unseeded cells. Error bars represent the SEM
of 5 independent experiments. *** p≤ 0.001 (two way paired ANOVA with Bonferroni post-test). b-e Scanning electron microscopy images
showing MSC seeded scaffolds after 14 days of culture in MSC expansion medium. Scale bars represent 2 mm (b, d) and 500 μm (c, e). Images are
representative of 3 independent experiments
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Interestingly, compared to uncultured CD271-enriched
BM-MNCs, we observed a higher DNA content and
higher ALP activity in native BM-MNCs (unselected and
uncultured) when seeded on the A-W scaffold. The
unselected heterogeneous BM-MNCs may contain yet un-
known accessory cells supporting MSC osteogenic poten-
tial. Most published work showing enhanced osteogenic
gene expression of uncultured CD271 positive BM-MNCs
used a highly purified CD271highCD45− cell population
isolated by FACS sorting [27, 32], whereas the present
study utilised CD271-enriched rather than purified cells,
which yield relatively lower frequency of CD271highCD45-
cells but still produced an average of over 1300-fold
increase in CD271highCD45- cells compared to non-
enriched BM-MNCs.
The main observed differences between the two cell
populations when seeded onto the scaffolds were:
 Different morphologies between the two A-W
scaffold seeded MSC populations. PA-MSCs had
elongated morphology and spread well on the
scaffold whilst CD271-MSCs displayed a more
round morphology and much sparse presence,
suggesting poor attachment to the scaffold.
 Significantly different population expansion kinetics
between the two populations (Fig. 4), with the PA-
MSCs showing a much higher initial growth rate.
 The PA-MSCs fully integrated with the scaffold, the
CD271-MSCs adhered to each other and formed a
“plate-like” covering on the scaffold surface.
 The PA-MSCs showed a stronger propensity for
osteogenic differentiation than CD271-MSCs when
seeded on the A-W scaffolds.
The difference in scaffold attachment between the two
MSC populations may have led to the population expan-
sion, integration and differentiation differences. Previous
research has shown that cells attached on stiff surfaces
are more likely to develop an elongated morphology and
undergo osteogenesis [33]. The connection between cell
shape and differentiation is due to the force required by
the cell to contract, and the strength with which the
cells are attached to the material that they are seeded on
[34]. Therefore, the strong and well-spread attachment
of PA-MSCs to the A-W scaffold could have contributed
to their higher osteogenic differentiation potential. The
differences seen in attachment could be due to differ-
ences in adhesion molecule expression between the two
populations. Such differences were not evident from
standard MSC phenotyping using ISCT criteria, and are
surprising given that the enriched cell population was
derived from the non-enriched – there remain quite
closely related cell populations. Improved understanding
of adhesion mechanisms for cell population and 3D scaf-
fold combinations would clearly help to enhance these
types of tissue engineering approaches.
It is also possible that the different cell populations
were affected through varying responses to stimuli from
the scaffolds. Solutions containing the ionic products of
bioactive glass ceramics are known to affect the prolifer-
ation rate in pre-osteoblast cells through alteration of
the cell cycle and activation of apoptosis [35–38].
Variable susceptibility of PA-MSCs and CD271-MSCs to
these stimuli could, at least partially, be an explanation
for the differences in proliferation kinetics. Another
suggestion [39] is that hydroxyapatite nanoparticles from
calcium phosphate based materials can influence the
Fig. 5 Osteogenic potential of A-W scaffold seeded PA-MSC and CD271-MSC. Scanning electron microscopy images (a-d) highlight areas of
matrix deposition (*) and nodule formations (<) on MSC seeded scaffold after 14 days of culture in osteogenic induction medium. Scale bars
represent 2 mm (a, c) and 50 μm (b, d). Images are representative of 3 independent experiments. Quantification of osteogenesis of paired MSCs is
shown through ALP activity normalised to the DNA content (e). Error bars represent the SEM of 3 independent experiments. The osteogenic
potential of non-cultured BM-MNCs seeded on A-W scaffolds, with or without CD271-enrichment, was presented as DNA quantification (f) and
ALP activity (g). Error bars represent the SEM of 3 independent experiments. *p = 0.026 (paired t-test)
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epigenetic status of bone marrow derived stromal cells.
As A-W forms a layer of hydroxyapatite on its surface
during the process of ionic dissolution, it is possible that
this mechanism played a part in the differences through
selective targeting of specific cell sub-populations.
Conclusions
This is the first study comparing the attachment, growth
kinetics, and osteogenic potential of A-W scaffold
seeded MSCs or BM-MNCs with or without CD271-
enrichment. The key findings lead to the conclusion that
an A-W scaffold seeded with unselected heterogeneous
cells, cultured or uncultured, will show a more potent
osteogenic potential than CD271-enriched cells, suggest-
ing that enrichment of CD271-positive population is not
beneficial for osteogenesis when the cells are cultured
on an A-W scaffold, with or without culture expansion.
Therefore, unselected heterogeneous cells (MSCs or
BM-MNCs) are more promising for A-W scaffold based
bone regeneration. In addition we conclude that care
should be exercised in using 2D cell culture to indicate
of likely performance of cell populations in a 3D scaffold
based system, even where the cell populations are closely
related – in this case one being an enriched population
derived from the same starting population.
Methods
Cells and cell culture
Bone marrow-derived mononuclear cells (BM-MNC)
were obtained using density gradient centrifugation over
Lymphoprep (Axis-Sheld, Oslo, Norway). CD271+ BM-
MNCs were isolated by immuno-magnetic positive
selection using QuadroMACS system and clinical grade
CD271 microbead kit (Miltenyi Biotec GmbH, Germany)
following manufacturer’s instructions. The unselected
and CD271-enriched BM-MNCs were then seeded into
T25 culture flasks and 6 well culture plates respectively
and cultured in good manufacturing practice (GMP)
compliant MSC expansion medium containing 10% FCS
(StemMACS, Miltenyi Biotec) at 37 °C in a 5% CO2
incubator. After 3 days, the non-adherent cells were
discarded with the replacement of culture medium. The
medium was changed twice weekly and cells were pas-
saged to a new flask when the culture reached 80% con-
fluence using standard Trypsin/EDTA (Sigma-Aldrich)
treatment. The MSCs derived from BM-MNCs with or
without CD271 enrichment were denoted as CD271-
MSC and PA-MSC respectively. Each paired PA-MSC
and CD271-MSC samples were generated from the same
bone marrow donation, seeded at the same density (4 ×
103/cm2) and cultured/passaged under identical condi-
tions. At each passage cell population doubling time was
recorded. MSCs at passage 3 were used in all experi-
ments throughout this work.
Flow cytometry analysis
Flow cytometry analysis was performed to monitor MSC
compliance with the phenotypic profile defined by the
International Society for Cellular Therapy (ISTC) and to
examine the frequency of CD271highCD45- cells in BM-
MNCs before and after CD271 enrichment. The cells were
stained with pre-optimised concentrations of antibodies
or appropriate isotype controls for 30min at 4 °C in FACS
buffer, containing PBS with 2% FCS and 1mM of endo-
toxin free ethylenediaminetetraacetic acid (EDTA). All
antibodies were supplied by BD Biosciences including
CD45-APC (HI30), CD271-PE (C40–1457), CD45-FITC
(2D1), CD34-FITC (581), CD19-FITC (4G7), CD14_FITC
(MφP9), HLA-DR-APC-H7 (L243), CD73-PE (AD2),
CD90-PerCPCy5.5 (5E10), CD105-APC (266). Data were
acquired on BD FACS Canto II cytometer and analysed
using FlowJo software (Tree Star).
Differentiation
In vitro differentiation was performed by culturing paired
MSCs in adipogenic, osteogenic or chondrogenic media (all
from Miltenyi Biotech), with media change twice a week.
2 × 105 and 3 × 104 cells were seeded in 6 well plates for
adipogenesis and osteogenesis respectively. For chondro-
genesis 2.5 × 105 cells were pelleted and cultured in 15ml
polypropylene conical tubes with media change twice a
week. Between 14 to 21 days of culture the cells were
washed in PBS and fixed with 10% formalin followed by
staining as previously described (Cuthbert et al., 2015).
Briefly, adipogenic cultures were stained for 10min at room
temperature with filtered 0.3% oil-red-O solution made
with oil-red-O powder (Sigma) in undiluted isopropanol
(Thermo-Fisher). After washing the cells were imaged to
show lipid vacuoles within adipocytes. Chondrogenic pellets
were paraffin embedded and sectioned (5 um) onto micro-
scope slides. The slides were stained overnight at room
temperature with 1% alcian blue (Sigma-Aldrich) solution
in 0.1N hydrogen chloride (HCL) (Thermo-Fisher), after
sequential incubation in xylene (Thermo-Fisher) and
decreasing concentrations of ethanol (Sigma), then imaged
to show proteoglycan deposition. Osteogenic cultures were
stained for both alkaline phosphatase (ALP) and mineralisa-
tion. ALP staining was performed overnight at 37 °C in a
substrate containing Napthol-AS-phosphate (Sigma-Al-
drich) and fast blue (Sigma-Aldrich) in 0.2M Tris HCl
solution (Thermo-Fisher, pH 9.0). After washing von Kossa
staining was applied by adding 3% Silver Nitrate solution in
dH2O and incubate for 1 h under direct light. Images of all
stained cells were acquired using an inverted Nikon TIRF/
Spinning Disk microscope.
Scaffold seeding
A-W scaffolds were produced using the process de-
scribed by Mancuso et al. [25]. Production involved the
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use of a Z Corp Z310 plus to print the 3D scaffolds from
the A-W powder, followed by sintering in a furnace at
1150 °C to create a porous bowl shaped structure. The
overall shape and size are illustrated in Fig. 6. Scaffolds
were sterilized in an autoclave at 121 °C for 20 min, in
accordance with previous work [23], soaked in PBS for
at least 24 h then transferred to a 48 well plate and
seeded with 5 × 104 MSCs or freshly isolated non-
expanded BM-MNCs in 20 μl StemMACS media. After
4–6 h incubation at 37 °C to allow cell adhesion, 1 ml of
StemMACS media or osteogenic media was added to
each well.
Quantification of DNA content and ALP activity
DNA quantification was performed using a Quant-iT™
PicoGreen® assay (Life Tech) according to the manufac-
tures recommendations. Briefly, the scaffold was incu-
bated on ice for 20 min with 1 ml of lysis buffer (150
mM sodium chloride (Sigma-Aldrich), 1% Triton X-100
(Sigma-Aldrich), 0.1% sodium dodecyl sulphate (SDS)
(Sigma-Aldrich) and 50 nM Tris (Thermo-Fisher, pH
8.0). The DNA standard was prepared at a range of
concentrations from 10 ng/ml to 1000 ng/ml. Standards
and cell lysates collected from the scaffolds were incu-
bated in duplicate with PicoGreen reagent at room
temperature in a 96 well plate for 5 min away from light
then analysed on a Fluostar Omega plate reader (BMG
Labtech). Quantification of ALP activity was performed
using a phosphate substrate p-nitrophenylphosphate
(pNPP) (Sigma-Aldrich) which produces p-nitrophenyl
(pNP) when reacts with ALP. Known concentrations of
pNP (Sigma-Aldrich) was used to generate a standard
curve ranging from 2 μg/ml to 139 μg/ml. Standards and
cell lysates collected from the scaffolds were incubated
with substrate solution in a 96 well plate at 37 °C for 1 h.
The reaction was stopped by 3M NaOH (BDH Lab sup-
plies) and the plate was read immediately at 405 nm on
a Multiskan Ascent microplate reader (Termo-Fisher).
Scanning confocal microscopy
Cell seeded scaffolds were cultured in expansion media
for 24 h to allow for full attachment. Following routine
wash and fixation the samples were stained with
Phalloidin (Sigma Aldrich, 1:1000 in 0.1% DPBS/Tween)
Fig. 6 Overall shape and size of A-W scaffolds. A-W scaffolds were produced using the process described by Mancuso et al. (2017). Production
involved the use of a Z Corp Z310 plus to print the 3D scaffolds from the A-W powder, followed by sintering in a furnace at 1150 °C to create a
porous bowl shaped structure
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for 1 h at room temperature away from light. After further
wash and mounting (Vectashield, with DAPI) the samples
were imaged using a Leica TCS SP2 UV AOBS MP up-
right scanning confocal microscope with a water-dipping
lens at × 20 magnification and 0.5 numerical aperture. To
reflect the whole sample and minimise bias, images were
acquired from at least 3 fields of each sample.
Scanning electron microscopy
Cell seeded scaffolds were cultured in either StemMACS
culture media or osteogenic induction media for 14 days
then washed in PBS and fixed in 2% Glutaraldehyde in
Sorenson’s Phosphate Buffer overnight. Scaffolds were
then washed in Sorenson’s buffer and dehydrated in
increasing concentrations of ethanol before being
transported to Electron Microscopy Research Services
(EMRS). After final dehydration with carbon dioxide in
a Baltec Critical Point Dryer the scaffolds were mounted
on aluminium stubs with Achesons Silver Dag, dried
overnight then gold coated with 10 nm of gold in a
Polaron Coating Unit. Scanning electron microscopy im-
ages were taken on a TESCAN VEGA SEM (Cambridge,
UK) housed in Electron Microscopy Research Services at
Newcastle University.
Statistical analyses
All statistical analyses were performed with GraphPad
Prism version 5 (GraphPad Software). Two-way paired
ANOVA bonferroni post-test and paired t-test were used
to determine statistical significance. Differences were
considered statistically significant at a p-value of < 0.05.
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